Is GlobalFoundries On The Verge Of A Breakout?
GLOBALFOUNDRIES Inc. (NASDAQ:GFS) is as a semiconductor foundry whose chips…
Sell
36
ENTA Quote, Financials, Valuation and Earnings
Last price:
$6.07
Seasonality move
:
-2.91%
Day range:
$5.84 - $6.10
52-week range:
$4.09 - $17.24
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.00x
P/B ratio:
1.39x
Volume:
148.3K
Avg. volume:
194.2K
1-year change:
-51.32%
Market cap:
$129.8M
Revenue:
$67.6M
EPS (TTM):
-$4.54
Enanta Pharmaceuticals SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
ENTA
Enanta Pharmaceuticals
|
05/08/2024 | 10-Q | 10-Q filing on 05/08/2024 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
02/08/2024 | 10-Q | 10-Q filing on 02/08/2024 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
08/08/2023 | 10-Q | 10-Q filing on 08/08/2023 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
05/09/2023 | 10-Q | 10-Q filing on 05/09/2023 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
02/08/2023 | 10-Q | 10-Q filing on 02/08/2023 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
08/08/2022 | 10-Q | 10-Q filing on 08/08/2022 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
05/09/2022 | 10-Q | 10-Q filing on 05/09/2022 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
02/10/2022 | 10-Q | 10-Q filing on 02/10/2022 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
08/09/2021 | 10-Q | 10-Q filing on 08/09/2021 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
05/10/2021 | 10-Q | 10-Q filing on 05/10/2021 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
02/09/2021 | 10-Q | 10-Q filing on 02/09/2021 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
11/25/2020 | 10-K | 10-K filing on 11/25/2020 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
08/10/2020 | 10-Q | 10-Q filing on 08/10/2020 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
05/11/2020 | 10-Q | 10-Q filing on 05/11/2020 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
02/10/2020 | 10-Q | 10-Q filing on 02/10/2020 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
11/27/2019 | 10-K | 10-K filing on 11/27/2019 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
08/09/2019 | 10-Q | 10-Q filing on 08/09/2019 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
05/10/2019 | 10-Q | 10-Q filing on 05/10/2019 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
02/08/2019 | 10-Q | 10-Q filing on 02/08/2019 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
11/29/2018 | 10-K | 10-K filing on 11/29/2018 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
08/09/2018 | 10-Q | 10-Q filing on 08/09/2018 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
05/10/2018 | 10-Q | 10-Q filing on 05/10/2018 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
02/09/2018 | 10-Q | 10-Q filing on 02/09/2018 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
12/11/2017 | 10-K | 10-K filing on 12/11/2017 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
08/09/2017 | 10-Q | 10-Q filing on 08/09/2017 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
05/10/2017 | 10-Q | 10-Q filing on 05/10/2017 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
02/09/2017 | 10-Q | 10-Q filing on 02/09/2017 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
01/06/2017 | 10-K | 10-K filing on 01/06/2017 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
12/09/2016 | 10-K | 10-K filing on 12/09/2016 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
08/09/2016 | 10-Q | 10-Q filing on 08/09/2016 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
05/10/2016 | 10-Q | 10-Q filing on 05/10/2016 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
02/09/2016 | 10-Q | 10-Q filing on 02/09/2016 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
12/11/2015 | 10-K | 10-K filing on 12/11/2015 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
08/10/2015 | 10-Q | 10-Q filing on 08/10/2015 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Dick’s Sporting Goods Buying Foot Locker Smart?
Last week, Dick’s Sporting Goods (NYSE:DKS) announced that it would…
Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Alerts
Buy
55
RGC alert for May 21
Regencell Bioscience Holdings [RGC] is up 31.16% over the past day.
Buy
64
AKRO alert for May 21
Akero Therapeutics [AKRO] is up 24.59% over the past day.
Buy
76
AGYS alert for May 21
Agilysys [AGYS] is up 22.13% over the past day.
